|
Market Closed -
Bombay S.E.
05:02:32 2026-11-05 EST
|
5-day change | 1st Jan Change | ||
| 444.30 INR | -2.23% |
|
-0.76% | +7.88% |
| 11-04 | Aarti Drugs Limited, Q2 2027 Earnings Call, Nov 04, 2026 | |
| 11-03 | Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
| Market Cap | 40.55B 429M 382M 351M 319M 599M 613M 4.19B 1.68B 21.46B 1.61B 1.58B 67.99B | P/E 2027 * |
-
| P/E 2028 * | 15.9x |
|---|---|---|---|---|---|
| Enterprise Value | 40.55B 429M 382M 351M 319M 599M 613M 4.19B 1.68B 21.46B 1.61B 1.58B 67.99B | EV / Sales 2027 * |
1.38x | EV / Sales 2028 * | 1.24x |
| Free-Float |
40.44% | Yield 2027 * |
1.33% | Yield 2028 * | 1.58% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -2.23% | ||
| 1 week | -0.76% | ||
| Current month | +1.97% | ||
| 1 month | +5.27% | ||
| 3 months | +7.24% | ||
| 6 months | +12.51% | ||
| Current year | +7.88% |
| 1 week | 433.1 |  | 500 |
| 1 month | 369 | | 500 |
| Current year | 318.6 | | 500 |
| 1 year | 318.6 | | 533.6 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 645 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 2019-04-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 1987-01-01 | |
| Director/Board Member | 63 | 2007-05-31 | |
| Chairman | 52 | 2026-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.23% | -0.76% | -11.76% | -3.44% | 439M | |
| -0.81% | +3.36% | +53.36% | +138.55% | 1,263B | |
| +0.00% | +1.05% | +49.51% | +83.32% | 665B | |
| -0.17% | +1.84% | +36.62% | +109.73% | 521B | |
| -0.93% | -2.36% | +47.94% | +65.38% | 387B | |
| -0.08% | +2.99% | +78.58% | +44.44% | 371B | |
| +0.38% | +1.83% | +32.62% | +59.92% | 310B | |
| +0.61% | +8.24% | +13.48% | +37.49% | 293B | |
| -1.89% | +1.65% | +46.42% | +71.66% | 259B | |
| -1.52% | +4.38% | +41.03% | +113.05% | 216B | |
| Average | -0.70% | +5.18% | +38.78% | +72.01% | 428.58B | |
| Weighted average by Cap. | -0.51% | +5.96% | +47.15% | +93.79% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 312M 278M 255M 231M 435M 445M 3.04B 1.22B 15.59B 1.17B 1.14B 49.38B | 32.69B 346M 308M 283M 257M 483M 494M 3.38B 1.35B 17.3B 1.3B 1.27B 54.8B |
| Net income | 2.15B 22.77M 20.29M 18.61M 16.91M 31.79M 32.52M 222M 89.16M 1.14B 85.47M 83.64M 3.61B | 2.55B 26.94M 24.01M 22.02M 20.01M 37.61M 38.47M 263M 105M 1.35B 101M 98.96M 4.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-05 | ₹444.30 | -2.23% | 23,113 |
| 26-11-04 | ₹454.45 | -2.39% | 171,233 |
| 26-11-03 | ₹465.60 | +2.60% | 54,012 |
| 26-11-02 | ₹453.80 | +4.15% | 35,290 |
| 26-10-30 | ₹435.70 | -2.95% | 11,647 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
